Hong Kong
· Delayed Price · Currency is HKD Sichuan Kelun-Biotech Biopharmaceutical Company Description
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs to address unmet medical needs in the People’s Republic of China and internationally.
The company is developing various drugs to treat breast, non-small cell lung, and gastrointestinal cancer, as well as non-oncology diseases.
Its product pipeline includes oncology drug candidates, such as SKB264 (sacituzumab tirumotecan), A166 (trastuzumab botidotin), SKB315, A167 (tagitanlimab), A140, and A400; and non-oncology drug candidates primarily to treat immune-mediated diseases, consisting of rheumatoid arthritis and alopecia areata comprising A223, A277, SKB378, and SKB336.
The company has license and collaboration arrangements with Merck Sharp & Dohme LLC; Harbour BioMed Therapeutics Limited; and Ellipses Pharma Limited.
The company was incorporated in 2016 and is headquartered in Chengdu, the People’s Republic of China.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,477 |
| CEO | Junyou Ge |
Contact Details
Address: No. 666 Xinhua Avenue Chengdu China | |
| Website | kelun-biotech.com |
Stock Details
| Ticker Symbol | 6990 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Junyou Ge | President, Chief Executive Officer, Chief Operating Officer, GM and Executive Director |
| Zejian Zhou | Chief Financial Officer and Joint Company Secretary |
| Yong Guo | Deputy GM, Chief Commercial Officer and Chief Marketing Officer |
| Yi Feng | Deputy GM, Chief Strategy Officer and Senior Vice President |
| Dr. Xiangyang Tan | Deputy GM and Chief Scientific Officer of Biologics' Research and Development |
| Dr. Xiaoping Jin | Deputy GM and Chief Medical Officer |
| Wai Sum Fung A.C.I.S., A.C.S. | Joint Company Secretary |